Risks and limits of Mikrobiom Frauen

Microbiome tests marketed to women often promise personalized health insights, but the evidence base remains weak. The gut microbiota fluctuates with menstrual cycle, pregnancy, menopause, and diet – a single snapshot cannot capture this dynamic state. Most commercial tests lack clinical validation for diagnosis and risk overinterpretation. Potential harms include unnecessary dietary restrictions, false reassurance, and neglect of underlying medical conditions. Sex-specific microbiome recommendations are largely derived from mechanistic or animal studies, not robust human trials. MyBody-X itself states its test offers 'inspiration' not medical advice. For conditions like IBS or recurrent UTIs, a physician-supervised microbiome analysis may be useful, but home tests are not a substitute. Key limits: no longitudinal validation, small effect sizes of reported associations, and marketing hype. Users should view results as general dietary guidance, not diagnostic tools. Privacy of genetic and microbial data is another concern. In summary, while microbiome research is promising, current consumer tests for women have significant scientific and practical limitations.